ProCE Banner Activity

Research for Prevention: Key Studies to Look Out For at HIVR4P 2024

Conference Coverage
Clinical Thought

Key studies that will be presented at HIVR4P 2024 include clinical and real-world implementation studies of long-acting PrEP options, and studies addressing the needs of transgender and cisgender individuals.

Released: October 04, 2024

Expiration: October 03, 2025

Share

Faculty

Beatriz Grinsztejn

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

Beatriz Grinsztejn, MD, PhD: consultant/advisor: Gilead, Merck, ViiV.